Rui Pedro Marques

2PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Mar 08, 2020
Cetuximab versus bevacizumab in metastatic colorectal cancer: a comparative effectiveness study.

Rui Pedro Marques, Ana Rita Godinho, Peter Heudtlass

|May 01, 2019
Patient-reported outcomes and health-related quality of life for cetuximab versus bevacizumab in metastatic colorectal cancer: a prospective cohort study.

Rui Pedro Marques, Peter Heudtlass, Helena Luna Pais

Pageof 1

Frequent Collaborators